Culture

NHGRI proposes an action agenda for building a diverse genomics workforce

The National Human Genome Research Institute (NHGRI) within the National Institutes of Health (NIH) has released a new action agenda for a diverse genomics workforce. This ambitious set of goals, objectives, and implementation strategies details NHGRI's plans for enhancing the diversity of the genomics workforce by 2030.

"To reach its full potential, the field of genomics requires a workforce that better reflects the diversity of the U.S. population," NHGRI Director Eric Green, M.D., Ph.D., said. "Fostering an appropriately diverse genomics workforce of the future requires an immediate and substantial commitment of attention and resources. Our new action agenda aims to bring both short- and long-term changes that will make genomics a more-inclusive discipline."

Accompanying the release of this action agenda today is a commentary authored by Dr. Green and Vence Bonham, J.D., senior advisor to the NHGRI director on genomics and health disparities, in the latest issue of ASHG's American Journal of Human Genetics, which explains the strategic imperative to make the genomics workforce more diverse.

A critical first step in implementing the action agenda is a comprehensive survey announced today by the American Society of Human Genetics, in cooperation with the American College of Medical Genetics and Genomics, the National Society of Genetic Counselors and others, to collect baseline data on the existing demographic landscape of the U.S. human genetics and genomics workforce. The survey will be launched in mid-to-late January.

The action agenda is a direct extension of the 2020 NHGRI Strategic Vision for the future of human genomics. The vision identifies priorities and opportunities for the next decade -- both within research and the research community-at-large -- to improve human health at The Forefront of Genomics.

A key priority that the strategic vision emphasizes is championing a diverse genomics workforce because "the promise of genomics cannot be fully achieved without attracting, developing, and retaining a diverse workforce, which includes individuals from groups that are currently underrepresented in the genomics enterprise."

To develop an overarching plan for this priority area, NHGRI established an internal Genomic Workforce Diversity Working Group last year. Chaired by Bonham, the group worked in earnest to develop the new action agenda.

"We listened to as many voices as possible as we were building the action agenda," Bonham said. "We actively sought broad input by seeking public comments and interviewed research university leaders and early career genomics professionals. This outreach has led to a plan that will propel the genomics field to make a much-needed change to our workforce."

The action agenda highlights groups that have been identified by NIH as underrepresented in biomedical, clinical, behavioral and social sciences. These groups include individuals from underrepresented racial and ethnic groups and disadvantaged backgrounds, persons with disabilities and women at the senior faculty level.

The plan describes four major goals:

Develop and support initiatives that provide early exposure and access to careers in genomics.

Develop and support training programs and networks that connect undergraduate and graduate education to careers in genomics.

Develop and support training, career development and research transition programs that lead to independent research and clinical careers in genomics.

Evaluate progress towards achieving greater diversity in the genomics workforce.

The new action agenda aims to build on NHGRI's history of funding diversity training programs, many of which have successfully helped to increase the number of underrepresented scientists who pursue genomics-related careers. The institute has also supported science education programs that provide genomics training to secondary school teachers, community college staff and tribal college and university faculty.

"With programs in place and new ones to start, the challenging but essential work begins now. Through sustained effort, dedication and creativity, we believe we can make the genomics workforce better reflect our diverse society," Dr. Green said.

Credit: 
NIH/National Human Genome Research Institute

Noncognitive skills -- distinct from cognitive abilities -- are important to success across the life

Noncognitive skills and cognitive abilities are both important contributors to educational attainment -- the number of years of formal schooling that a person completes -- and lead to success across the life course, according to a new study from an international team led by researchers at Columbia University Mailman School of Public Health, the University of Texas at Austin, and Vrije Universiteit Amsterdam. The research provides evidence for the idea that inheriting genes that affect things other than cognitive ability are important for understanding differences in people's life outcomes. Until now there had been questions about what these noncognitive skills are and how much they really matter for life outcomes. The new findings are published in the journal Nature Genetics.

"Genetic studies of educational attainment were initiated with the goal of identifying genes that influenced cognitive abilities. They've had some success in doing that. But it turns out they've also identified genetics that influence a range of other skills and characteristics.," said Daniel Belsky, PhD, assistant professor of epidemiology. "What was most surprising to me about our results was that these noncognitive skills contributed just as much to the heritability of educational attainment as cognitive ability." Of the total genetic influence on educational attainment, referred to as the heritability, cognitive abilities accounted for 43 percent and noncognitive skills accounted for 57 percent.

Similar to the genetics of cognitive abilities, the genetics of noncognitive skills were related to achievements outside of schooling, including holding more prestigious jobs, earning higher incomes, and living longer. And, genes associated with noncognitive skills showed relationships with these other life outcomes that were as strong or stronger than the relationships seen with cognitive genetics. "These results were important proof of concept," observed Belsky, who is also with the Robert N Butler Columbia Aging Center. "They showed us that noncognitive skills genetics have implications for economics and public health similar to the genetics of cognitive abilities."

The study used a method called a "genome-wide association study," or GWAS, to study what economists have called "noncognitive skills,"defined as behaviors and abilities that are not measured by traditional IQ tests but are thought to help people be more successful in school, in their jobs, and in life generally. The study builds on results from a previous study that conducted a GWAS of educational attainment. The researchers applied a new statistical method to develop an understanding of the substance of noncognitive skills, and how genetic correlations with noncognitive skills diverged from genetic correlations with cognitive abilities, as measured by standardized tests of IQ.

"Borrowing a strategy from economists who studied people with the same cognitive ability but different years of education enabled us to associate the variations in how far people go in school above and beyond their association with cognitive test performance. We were able to conduct this type of analysis using a new method we developed called Genomic Structural Equation Modeling, which is a way of combining data from multiple GWASs at the same time," said Michel Nivard, assistant professor of biological psychology at the Vrije Universiteit Amsterdam and co-leader of the study. "This approach allows us to leverage the power of giant genetic databases like UK Biobank to study the genetics of traits and behaviors that were not directly measured in the research participants." Using this novel method, the researchers were able to conduct GWAS of noncognitive skills in data from hundreds of thousands of individuals.

"Our GWAS identified 157 different locations in the human genome that related to noncognitive skills.," said Perline Demange, a PhD candidate in biological psychology at the Vrije University, Amsterdam and a lead author of the paper together with Margherita Malanchini, lecturer in psychology at the Queen Mary University of London. "Our GWAS identified signals from genes that are disproportionately active in brain tissues, similar to what has been found for the genetics of cognitive abilities."

The individual genetic associations discovered in the GWAS were very small in magnitude. "Any individual genetic variant really had a trivial influence on the phenotype.," explained Malanchini, "However, by adding up these tiny associations, we can create composite measures called polygenic scores. These measures can then be applied to genetic data from research participants to estimate how likely someone is to show a particular outcome (or phenotype)." In this paper, polygenic scores were created in six data U.K., and New sets from people born at different times throughout the 20th century in the Netherlands, the U.S., the Zealand. They also calculated genetic correlations between noncognitive skills and other phenotypes that have been the focus of large GWASs, such as obesity, smoking, and psychiatric diseases.

Overall, the genetics of noncognitive skills were associated with higher tolerance of risks, greater willingness to forego immediate gratification, less health-risk behavior, and delayed fertility. Researchers also observed that noncognitive skill genetics were associated with a constellation of personality traits linked with success in relationships and at work, such as being curious and eager to learn, being more emotionally stable, and being more industrious and orderly.

"There has been much debate about what noncognitive skills are and how best to measure them. Motivation, persistence, grit, curiosity, self-control, growth mindset -- these are just a few of the things that people have suggested are important noncognitive skills," observed Paige Harden, professor of psychology at the University of Texas at Austin and a co-leader of the research along with Belsky and Nivard. "For personality and risk behavior, we saw relationships we expected; noncognitive skills genetics were associated with less risky behavior and a personality profile we associate with maturity, and social and professional competency," said Harden. But the results for mental health were a surprise."

The researchers found that noncognitive skills genetics that were associated with educational attainment were also associated with increased risk for schizophrenia, bipolar disorder, obsessive compulsive disorder, and anorexia nervosa. "This is an example of what geneticists call pleiotropy.," explained Harden. "Our result warns us against a simplistic view of genetic variants being good or bad. The same genetic variant that predisposes someone to go further in school might also elevate their risk of developing schizophrenia or another serious mental disorder."

The authors also released an FAQ to accompany their paper, which warns against using the results of this study - or any genetic research - as evidence that children's educational performance or noncognitive skills cannot be improved with intervention or policy. Harden cautions that, "Genetic influence must always be understood through the lens of history and social structures. These results tell us about what is, not what could be. Nothing about our study should discourage investments in ensuring that all children reach their maximum potential."

Credit: 
Columbia University's Mailman School of Public Health

SARS-CoV-2 transmission from people without COVID-19 symptoms

What The Study Did: Under a range of assumptions of presymptomatic transmission and transmission from individuals with infection who never develop symptoms, the model presented here estimated that more than half of transmission comes from asymptomatic individuals.

Author: Jay C. Butler, M.D., of the U.S. Centers for Disease Control and Prevention in Atlanta, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2020.35057)

Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Adapting to COVID-19 with outdoor intraocular pressure monitoring

What The Study Did: To adapt to broader public health initiatives around COVID-19, researchers developed a drive-through intraocular pressure (IOP) screening clinic to minimize COVID-19 exposure for patients and clinicians by measuring eye pressure in the unconventional setting of a clinic parking lot.

Authors: Miel Sundararajan, M.D., of the University of California, San Francisco, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamaophthalmol.2020.6073)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Virtual care at cancer center during COVID-19

What The Study Did: The outcomes of a cancer center-wide virtual care program launched in response to the COVID-19 pandemic were examined in this study.

Authors: Alejandro Berlin, M.D., M.Sc., of the Princess Margaret Cancer Centre in Toronto, Ontario, Canada, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaoncol.2020.6982)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Assessment of duplicate evidence in systematic reviews of imaging findings of children with COVID-19

What The Study Did:This cross-sectional study maps a coronavirus research question to illustrate the overlap and shortcomings of the evidence syntheses in this area.

Author: Giordano Pérez-Gaxiola, M.D., M.Sc., of Sinaloa Pediatric Hospital's Cochrane Associate Centre in Culiacan, Mexico, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2020.32769)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Significant number of patients with sudden loss of consciousness need pre-hospital critical care

Research from life-saving charity Air Ambulance Kent Surrey Sussex (KSS) in partnership with the University of Surrey has shown the benefits of dispatching HEMS to patients with a sudden, unexplained LOC of medical origin and a high prevalence of acute neurological pathology.

The study - which is believed to be the first published about HEMS dispatch to non-trauma (neuro) cases - also highlights how HEMS dispatchers in dialogue with ambulance personnel are able to select patients requiring HEMS-specific interventions and, based on its findings, identifies opportunities to improve triage for these patients.

Through a retrospective study of all patients with a LOC attended by KSS between 2nd July 2013 and 19th December 2017 the research found:

127 patients with unexplained LOC were attended by KSS, with KSS being dispatched directly to 25% of the patients and 75% on request of the ground ambulance crews

KSS was required to perform a specialist HEMS intervention in 65% of these patients

77% of these patients were conveyed to hospital by KSS

Sudden LOC in the pre-hospital setting in the absence of cardiac arrest and seizure activity presents a challenge from a dispatcher's perspective: the aetiology is varied, with many causes being transient and mostly self-limiting.

However, other causes are potentially life-threatening, with patients requiring the expertise of HEMS. HEMS teams have enhanced knowledge and skills which mean they are able to deliver specific advanced treatments, ordinarily only available in hospital, which can address some of the cause of the LOC. HEMS involvement has been shown to shorten scene times for critically ill patients , and expedite transport times to hospital.

But HEMS is a scarce resource and, as this study shows, there is an opportunity to improve triage for non-trauma patients. This will enable greater accuracy and will potentially help more patients presenting with unexplained life-threatening LOC.

Commenting, Professor Richard Lyon MBE, Associate Medical Director at KSS and Professor in Pre-Hospital Emergency Care at the University of Surrey said:

"We know specialist interventions, like emergency anaesthesia, when delivered at the scene of an accident, can significantly improve the outcome for patients with traumatic brain injury. This study highlights there is a group of patients who suffer sudden neurological emergencies who may also benefit from the air ambulance attending to rapidly deliver hospital-level intensive care."

"HEMS is a valuable but scarce medical resource so it is crucial the HEMS crew is tasked to those patients likely to have the most benefit. KSS is a charity, reliant upon public donations and fundraising for the £15 million it costs each year to deliver its service for the 4.8 million people it serves."

"Improving triage for these patients is key, so that those patients who need immediate critical care, receive it as quickly as possible. Further research, in partnership with the University of Surrey, is now underway to explore how to improve air ambulance dispatch to medical cases, including exploring using live video footage from 999 callers."

Credit: 
University of Surrey

Mount Sinai researchers identify and characterize 3 molecular subtypes of Alzheimer's

(New York, NY - January 6, 2021) - Researchers at the Icahn School of Medicine at Mount Sinai have identified three major molecular subtypes of Alzheimer's disease (AD) using data from RNA sequencing. The study advances our understanding of the mechanisms of AD and could pave the way for developing novel, personalized therapeutics.

The work was funded by the National Institute on Aging, part of the National Institutes of Health (NIH), and published in Science Advances on January 6, 2021.

RNA is a genetic molecule similar to DNA that encodes the instructions for making proteins. RNA sequencing is a technology that reveals the presence and quantity of RNA in a biological sample such as a brain slice.

Alzheimer's disease is the most common form of dementia, but it is quite diverse in its biological and pathological manifestations. There is growing evidence that disease progression and responses to interventions differ significantly among Alzheimer's patients. Some patients have slow cognitive decline while others decline rapidly; some have significant memory loss and an inability to remember new information while others do not; and some patients experience psychosis and/or depression associated with AD while others do not.

"Such differences strongly suggest there are subtypes of AD with different biological and molecular factors driving disease progression," said Bin Zhang, PhD, the lead author of the study, Director of the Center for Transformative Disease Modeling, and Professor of Genetics and Genomic Sciences at the Icahn School of Medicine.

To identify the molecular subtypes of AD, the researchers used a computational biology approach to illuminate the relationships among different types of RNA, clinical and pathological traits, and other biological factors that potentially drive the disease's progress. The research team analyzed RNA-sequencing data of more than 1,500 samples across five brain regions from hundreds of deceased patients with AD and normal controls, and identified three major

molecular subtypes of AD. These AD subtypes were independent of age and disease stage, and were replicated across multiple brain regions in two cohort studies.

These subtypes correspond to different combinations of multiple dysregulated biological pathways leading to brain degeneration. Tau neurofibrillary tangle and amyloid-beta plaque, two neuropathological hallmarks of AD, are significantly increased only in certain subtypes.

Many recent studies have shown that an elevated immune response may help cause Alzheimer's. However, more than half of AD brains don't show increased immune response compared to normal healthy brains. The analysis further revealed subtype-specific molecular drivers in AD progression in these samples. The research also identified the correspondence between these molecular subtypes and the existing AD animal models used for mechanistic studies and for testing candidate therapeutics, which may partially explain why a vast majority of drugs that succeeded in certain mouse models failed in human AD trials, which likely had participants belonging to different molecular subtypes.

Although the subtyping described by the researchers was performed post mortem using the patients' brain tissue, the researchers said that if the findings were validated by future studies, they could lead to the identification in living patients of biomarkers and clinical features associated with these molecular subtypes and earlier diagnosis and intervention.

"Our systematic identification and characterization of the robust molecular subtypes of AD reveal many new signaling pathways dysregulated in AD and pinpoint new targets," said Dr. Zhang, "These findings lay down a foundation for determining more effective biomarkers for early prediction of AD, studying causal mechanisms of AD, developing next-generation therapeutics for AD and designing more effective and targeted clinical trials, ultimately leading to precision medicine for AD. The remaining challenges for future research include replication of the findings in larger cohorts, validation of subtype specific targets and mechanisms, identification of peripheral biomarkers and clinical features associated with these molecular subtypes."

The AD subtyping study is supported by the NIH National Institute on Aging (NIA) and is part of the NIA-led Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD) Target Discovery and Preclinical Validation program. This public private partnership aims to shorten the time between the discovery of potential drug targets and the development of new drugs for Alzheimer's disease treatment and prevention.

Credit: 
The Mount Sinai Hospital / Mount Sinai School of Medicine

Unusual sex chromosomes of platypus, emu and duck

image: New methods have shown that platypus has ten sex chromosomes.

Image: 
© Doug Gimesy

Sex chromosomes are presumed to originate from a pair of identical ancestral chromosomes by acquiring a male- or a female-determining gene on one chromosome. To prevent the sex-determining gene from appearing in the opposite sex, recombination is suppressed on sex chromosomes. This leads to the degeneration of Y chromosome (or the W chromosome in case of birds) and the morphological difference of sex chromosomes between sexes. For example, the human Y chromosome bears only less than 50 genes, while the human X chromosome still maintains over 1500 genes from the autosomal ancestor. This process occurred independently in birds, in monotremes (the Australian platypus and echidnas), and in the other mammals (therians, e.g., kangaroo, mouse and human etc.).

Platypus has ten sex chromosomes

With its venom, duck-bill, egg, and milk, platypus features an extraordinary combination of reptiles, birds and mammals. Previous work showed that platypus, although undoubtedly a mammalian species, have sex chromosomes that do not share the same origin with those of human. It turns out that male platypus has five pairs of XY chromosomes (named as X1Y1, X2Y2, etc.), and none of them are homologous to the XY of human or mouse. These ten sex chromosomes pair with each other in a head-to-tail manner and form a chain during meiosis when sperm cells develop. The genetic makeup and the evolution process of such a complex and unique sex chromosome system remained unclear, because the previously published platypus genome is was from a female, and only a quarter of the sequences is was mapped onto chromosomes.

Cutting-edge sequencing techniques

An international team of researchers adopted a new sequencing technique (called PacBio, or third-generation sequencing) that can "read" the genome information for over 300-fold longer in length than the last-generation technique, and the new chromatin conformation capture technique that can connect and map the genomic sequences into the chromosome level.

"With further laborious cytogenetic experiments, we improved the genome quality and mapped over 98% of the sequences into 21 autosomes, and 5X and 5Y chromosomes of platypus" says Guojie Zhang from BGI-Shenzhen and University of Copenhagen. "The new genomes are a hugely valuable public resource for research in mammalian biology and evolution, with applications in wildlife conservation and even human health," says Frank Grützner at University of Adelaide in Australia.

From a ring to a chain

"What surprised us is that, from the new sex chromosome sequences, we found the last Y chromosome, Y5 does not share many sequences with its pairing X5 chromosome, but with the first X chromosome of the chain, X1", says Qi Zhou. "This suggested that the 10 platypus sex chromosomes used to be in a ring shape. Maybe the acquisition of a male-determining gene and suppression of recombination broke the ancestral chromosome ring into a chain". This part of the sex chromosome work provides an entirely new perspective on the evolution of this extraordinary sex chromosome system, along with other new discoveries of platypus genes related to milk production, loss of teeth and so on, were published in Nature as a research article.

Different sex systems of birds and mammals

With similar new techniques used for the platypus genome, the Zhou group simultaneously decoded the sex chromosome sequences of emu and Pekin duck, which represent the different phase of sex chromosome evolution. Most mammalian and bird species' sex chromosomes have evolved into their terminal stage of evolution like that of human or chicken. A key difference between mammals and birds is that instead of the XY sex system, birds have so-called ZW sex chromosomes. That is, male birds have a pair of ZZ chromosomes, female birds have a Z and a W sex chromosomes.

Slow-evolving sex chromosomes of emu and duck

The Y or W chromosomes usually have lost most functional genes, and become a "gene desert" full of repetitive sequences. Emu is an exception: its sex chromosomes are largely like a pair of autosomes, with over two-thirds of the sequences and active genes still shared between the Z and W chromosomes. "This may be related to the slower evolution rate of the emu compared to other birds'', says Jing Liu, a Ph.D. student in the Zhou group. "By comparing the genomes of emu and 11 other bird species, we found that large-bodied birds like emu and ostrich tend to have much less chromosome rearrangements than other birds".

Another possible reason is that these flightless large birds may undergo much weaker sexual selection, a potential driver for sex chromosome evolution, compared to other birds, given that male and female emus are largely monomorphic. This provides a great system to understand how sex chromosomes evolve in their early phase - and in the case of Pekin duck, in the middle phase. Another project from the Zhou group generated the high-quality genome sequence of Pekin duck, a very popular poultry species. Emu, duck and chicken together mark the different time phase of sex chromosome evolution.

In this work we found that the W chromosomes of emu and duck have retained many more functional genes on their W chromosomes compared to the chicken. Such a large variation in the tempo of sex chromosome evolution is not observed in mammals, and reflects the different evolutionary modes of the XY and ZW sex systems. These novel sex chromosome sequences of emu and duck will also provide important resources for poultry studies.

Credit: 
University of Vienna

How to mitigate the impact of a lockdown on mental health

The Covid-19 pandemic is impacting people's mental health. But what helps and hinders people in getting through a lockdown? A new study led by researchers at the University of Basel addressed this question using data from 78 countries across the world. The results hint at the pivots and hinges on which the individual's psyche rests in the pandemic.

At the outset of the Covid-19 pandemic, little was known about the impact of population-wide governmental lockdowns. What was known was taken from restricted quarantines of small groups of people. "On the one hand, such drastic changes to daily routines can be detrimental to mental health," explains Professor Andrew Gloster from the University of Basel, co-leader of the study now published in PLOS One. "On the other hand, because the entire population was more or less equally affected during the lockdown, it remained unclear whether this impact would occur."

To address this question, Gloster and his international colleagues conducted an online survey in 18 languages. Almost 10,000 people from 78 countries participated, giving information about their mental health and overall situation during the Covid-19 lockdown.

One in ten respondents reported low levels of mental health - including negative affect, stress, depressive behaviors and a pessimistic view of society. Another 50% had only moderate mental health, which has previously been found to be a risk factor for further complications. These figures are consistent with other studies addressing the impact of the pandemic on mental health.

Lowest levels of well-being in Hong Kong and Italy

Overall, the responses in the different surveyed countries were largely similar. However, although no country emerged as either consistently better or worse across all outcomes, there were some differences. Hong Kong and Turkey reported more stress than other countries; the USA reported more depressive symptoms; and well-being was lowest in Hong Kong and Italy. Participants in Austria, Germany and Switzerland, on the other hand, reported significantly fewer negative emotions (negative affect) than the average level across all countries.

These differences are likely due to a combination of chance, nation-specific responses to the pandemic, cultural differences and factors such as political unrest. Beyond that, they may in part be explained by factors the researchers found to be connected to outcomes. Loss of financial income compared to pre-lockdown levels and not having access to basic supplies were consistently associated with worse outcomes. Factors that consistently improved outcomes were having social support, higher education levels, and being able to respond and adapt flexibly to the situation.

"Public health initiatives should target people without social support and those whose finances worsen as a result of the lockdown. Based on these results, interventions that promote psychological flexibility like acceptance and commitment therapy hold promise when it comes to mitigating the impact of the pandemic and lockdowns," says Gloster. Given the continued fluid development of the pandemic and its economic consequences, attention to people's mental health remains important.

Credit: 
University of Basel

Ancient DNA analysis reveals Asian migration and plague

Northeastern Asia has a complex history of migrations and plague outbursts. That is the essence of an international archaeogenetic study published in Science Advances and lead from the Department of Archaeology and Classical Studies at Stockholm University. Genomic data from archaeological remains from 40 individuals excavated in northeastern Asia were explored in the study.

"It is striking that we find everything here, continuity as well as recurrent migrations and also disease-related bacteria", says Anders Götherström, professor at the Center for Palaeogenetics at Stockholm University and one of the Principal investigators of the study.

The scientists discovered that there were demographic events in the past common for the whole Lake Baikal region. For example, around 8300 years ago there was a migratory event discernible both east and west of Lake Baikal. But there were also events specific for each of the two areas. While the areas west of Lake Baikal provides evidence for recurrent migrations and intense mobility, the areas east of Lake Baikal preserved a long-term continuity for thousands of years, apparently with limited mobility from other areas.

"It is intriguing that our data reveals complex and contrasting patterns of demographic change in one of the least populated regions on earth; including notable gene flow and at the same time a genetic continuity without major demographic changes in the two areas around Lake Baikal", says lead-author Gulsah Merve Kilinc, former postdoctoral researcher at the Department of Archaeology and Classical Studies at Stockholm University and currently Lecturer at Department of Bioinformatics at Hacettepe University in Ankara.

The study also provides some new clues to the history of the Paleo-Inuit groups, the people who inhabited northern Greenland and Canada. While it has been suspected that the so called Belkachi-complex, a cultural group in the Baikal area, played a part in the early history of Paleo-Inuits, it has not been possible to evaluate this in detail. The analyses of remains of an individual associated with the Belkachi cultural-complex, dated to more than 6000 years before present now show that there is an association to a previously published Paleo Inuit (Saqqaq) individual (dated c.4000 yrs BP) on Greenland.

"This is the first genetic evidence of a link between a Neolithic period human group in Yakutia and the later Palaeo-Inuit groups, and this will inspire to new of research on the demographic development", says Jan Storå, Professor at Osteoarchaeological Research Laboratory at the Department of Archaeology and Classical Studies at Stockholm University.

Finally, the study provides new data on the most eastern occurrences of the bacteria Yersinia pestis, the plague. One individual from the Lena basin, dated to c. 3800 years ago, and buried with individuals that proved to be close kin genetically, carried DNA from Yersinia pestis. Also, an individual dated to c. 4400 years ago from the area west of Lake Baikal hosted Yersinia pestis. Interestingly, the population west of Lake Baikal seems to have decreased in size around 4400 years ago, judging from the genomic data.

"Despite a need for more data, our discovery of the decrease in effective population size that coincided with the appearance of Yersinia pestis points to a possible presence of a prehistoric plague - possibly a pandemic. However, this is just as an educated guess which needs to wait for confirmation", says Emrah K?rdök, former postdoctoral researcher at the Department of Archaeology and Classical Studies at Stockholm University and currently Lecturer at Mersin University in Turkey.

Credit: 
Stockholm University

Mediterranean diet may decrease risk of prostate cancer progression

In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease.

"Men with prostate cancer are motivated to find a way to impact the advancement of their disease and improve their quality of life," said Justin Gregg, M.D., assistant professor of Urology and lead author of the study, published today in Cancer. "A Mediterranean diet is non-invasive, good for overall health and, as shown by this study, has the potential to effect the progression of their cancer."

After adjusting for factors known to increase risk of cancer getting worse over time, such as age, prostate-specific antigen (PSA) and tumor volume, men with a diet that contained more fruits, vegetables, legumes, cereals and fish had a reduced risk of their prostate cancer growing or advancing to a point where many would consider active treatment. The researchers also examined the effect of diabetes and statin use and found a similar risk reduction in these patient groups.

The study, whose largest number of participants were white, also found that the effect of a Mediterranean diet was more pronounced in African American participants and others who self-identified as non-white. These findings are significant as the rate of prostate cancer diagnosis is more than 50% higher in African American men, who also have a higher risk of prostate cancer death and disease progression.

"The Mediterranean diet consistently has been linked to lower risk of cancer, cardiovascular disease and mortality. This study in men with early stage prostate cancer gets us another step closer to providing evidence-based dietary recommendations to optimize outcomes in cancer patients, who along with their families, have many questions in this area," said Carrie Daniel-MacDougall, Ph.D., associate professor of Epidemiology and senior author of the study.

After skin cancer, prostate cancer is the most common cancer in men in the United States. Since most cases are low-risk disease, localized to the prostate and have favorable outcomes, many men do not need immediate treatment and opt for active surveillance by their doctor. Treatments for prostate cancer can cause changes in quality of life and declines in urinary and sexual function, therefore there is interest in finding modifiable factors for men managed by active surveillance.

The study followed 410 men on an active surveillance protocol with Gleason grade group 1 or 2 localized prostate cancer. All study participants underwent a confirmatory biopsy at the beginning of the study and were evaluated every six months through clinical exam and laboratory studies of serum antigen PSA and testosterone.

Trial participants were 82.9% Caucasian, 8.1% Black and 9% other or unknown. The median age was 64, 15% of the men were diabetic and 44% used statins.

The men completed a 170-item baseline food frequency questionnaire, and Mediterranean diet score was calculated for each participant across 9 energy-adjusted food groups. The participants were then divided into three groups of high, medium and low adherence to the diet.

After adjustments for age and clinical characteristics, researchers saw a significant association between high baseline diet score and lower risk of cancer grade progression. For every one-point increase in the Mediterranean diet score, researchers observed a >10% lower risk of progression. After a median follow-up of 36 months, 76 men saw their cancer progress.

The study was limited by the low number of events in these men with mostly low risk disease monitored at MD Anderson. Future research is needed to see if the same effects are seen for larger and more diverse patient groups and men with higher-risk prostate cancer.

"Our findings suggest that consistently following a diet rich in plant foods, fish and a healthy balance of monounsaturated fats may be beneficial for men diagnosed with early-stage prostate cancer," Gregg said. "We are hopeful that these results, paired with additional research and future validation, will encourage patients to adapt a healthy lifestyle."

Credit: 
University of Texas M. D. Anderson Cancer Center

Cell Press papers to highlight research teams' inclusion and diversity efforts

Scientists who publish in Cell Press research journals (e.g., Cell, Joule, Current Biology, etc.) will now have the option to include a short statement that highlights elements of the study design and/or author characteristics that are relevant to inclusion and diversity. The statement is generated based on information provided on a dedicated inclusion and diversity form that study authors complete as part of the acceptance process. This pilot initiative will also allow Cell Press to better collect, analyze, and share back data about research teams' general inclusion and diversity efforts.

"In an ideal world, science would cover and be conducted by as broad a range of individuals as exist in global society, with everyone who wants to participate both being and feeling welcomed as part of the overall scientific community. Currently, however, the scientific enterprise is a long way from such inclusion and diversity," says Anne Kitson, Managing Director, Cell Press and The Lancet. "We want to find ways to push for positive change through the platform of our journals. As part of that, we see an opportunity to give authors the ability to share efforts that that they are making too."

The concept underlying this initiative is similar to existing statements about declarations of interests, author contributions, and data and code availability but focuses on highlighting aspects of the paper that are relevant to inclusion and diversity. It is purposely multifunctional and designed to give authors a venue to express ways in which their work, their research group, or both are contributing to helping science become more inclusive and diverse. It also reflects the focus of Elsevier's Inclusion and Diversity Board and a broader commitment to promoting women in science as well as racial, ethnic and geographic diversity in editorial boards, peer review and scientific conferences while supporting publication and inclusive participation in research.

Researchers can include information about efforts to ensure diversity in cell lines or genomic datasets used for a study, efforts to ensure sex/gender balance in research subjects, efforts to ensure that any study questionnaires are prepared in an inclusive way, efforts to avoid "helicopter science," self-identification of authors as members minority groups, support that any authors have received from programs designed to support minority scientists, and efforts made to promote gender balance in citation lists.

For example, one paper's inclusion and diversity statement could read: "We worked to ensure sex balance in the selection of non-human subjects. One or more of the authors of this paper self-identifies as living with a disability. One or more of the authors of this paper received support from a program designed to increase minority representation in science." Cell Press will run this program as a pilot during the course of 2021 and then decide whether to continue, adapt, or build on it towards the end of the year. The first iteration will focus on research articles only.

"Any research group that doesn't want to publish a statement will not be required, but Cell Press will keep the data submitted via the inclusion and diversity forms for aggregated reporting. "We need to have data to help us monitor progress. We hope to be able to use it to benchmark and set goals for the types of inclusion and diversity efforts that Cell Press and our authors are making," says John Pham, Editor-in-Chief of Cell. "For example, we would like to be able to report how many of our papers have at least one minority scientist among the author group or made efforts to consider diversity in the selection of experimental materials or samples. We can then develop ways to challenge ourselves and the community to increase diversity and monitor outcomes."

"We hope that this new inclusion and diversity initiative will give our authors a powerful opportunity to share their contributions in a visible way within the context of their article," says Deborah Sweet, Cell Press Vice President of Editorial. "We see it as a way to acknowledge current authors who have worked to improve inclusion and diversity in science and encourage others to do more going forward. We also hope it will be a source of inspiration and confidence within the scientific community and beyond."

Credit: 
Cell Press

Simple bioreactor makes 'gut check' more practical

image: Researchers at Rice University and Baylor College of Medicine developed millifluidic perfusion cassettes (mPCs) that mimic conditions in the intestines to evaluate infections like those that cause diarrhea. The devices formed from 3D-printed molds (top right) were seeded with intestinal enteroid cultures (IECs) and infected with pathogens for 24 hours or more to see how infections take hold.

Image: 
Rice University/Baylor College of Medicine

HOUSTON - (Jan. 7, 2021) - Rice University and Baylor College of Medicine researchers have found a way to mimic conditions in intestines, giving them a mechanical model for the real-time growth of bacterial infections.

In a new study, they demonstrate a lab tool that simplifies simulations of the human intestine, making it more practical to find treatments for diseases like infectious diarrhea.

The team led by bioengineer Jane Grande-Allen of Rice's Brown School of Engineering developed transparent millifluidic perfusion cassettes (mPCs) that are easy to fabricate and operate and compatible with common microscopic and biochemical analysis.

The cassettes allow even non-bioengineers to perform the kind of studies typically done with a 96-well petri dish, with the added benefit of fluid flow over seeded epithelial cells infected with bacteria. The cassettes also have micro-scale ports for input and output, allowing not only for fluid flow but also for sampling of the environment.

The study led by Grande-Allen, Rice's Isabel C. Cameron Professor of Bioengineering, and lead author and Rice and Baylor M.D./Ph.D. alumnus Reid Wilson, currently a resident at Oregon Health and Science University, appears in the Annals of Biomedical Engineering.

Replicating the complicated human gut is a challenge for researchers, said co-author Anthony Maresso, an associate professor of molecular virology and microbiology at Baylor. "Devices like these are often not user-friendly and practical for biologists like myself," he said. "This one was designed to be easy to use by scientists with less engineering know-how. The hope is it will lower barriers between engineers and medical researchers."

Grande-Allen said making a microfluidic system that doesn't leak can be technically challenging. "In this case, we needed to mimic the rate of fluid throughout the intestine that, especially compared to blood, is really slow," she said.

Molds of the devices, about the size of standard 96-well plates, were created with a 3D printer and used to form the clear polymer cassettes. The mPCs were seeded with human intestinal enteroids (HIEs), cultures that contain the major cell types native to the intestinal epithelium. When fluid containing bacteria flowed through, it formed a biofilm on the cells, a phenomenon not seen in static platforms.

Researchers can easily evaluate how well bacteria adhere to and infect the cells, both visually and by sampling through the ports on either end. Static plates allow bacteria to overgrow the cells and limit experiments to a few hours, but the slow flow through mPCs allows extended observation and more realistic results, Grande-Allen said.

Testing the device led the researchers to find the first direct evidence that aggregative adherence fimbriae, sticky appendages found on most infectious enteroaggregative Escherichia coli (EAEC), are necessary for the bacteria to form a biofilm.

"Our intention was to slowly flush the bacterial toxins to keep them from harming the cells," Grande-Allen said. "That allowed more cells to survive so we could watch the process of infection. We were completely surprised to see that it also dramatically changed the nature of the film that formed."

The devices also keep HIE cultures alive by replenishing oxygen and nutrients in the mPC chamber, allowing for better evaluation of realistic interactions between the cells and invading pathogens, Grande-Allen said.

She said mPCs will facilitate research on many such interactions. "This will allow the systematic examination of a lot of different combinations, good and bad, and how flow changes the dynamics of this environment," she said.

Credit: 
Rice University

Tech giant technology is 'open source' for the pandemic, so why does it feel so closed?

The COVID-19 pandemic has seen hardware developers clamouring to make 'open source' technology to support our frontline services. Their intentions have been honourable - an invitation to teams across the world to collaborate in developing essential equipment such as ventilators, thereby making the process of producing critical instruments more effective, both in time and cost.

In practice, however, most developers of hardware have shown little 'openness' in their sharing of designs, a fact lamented by a group of physicists from the University of Bath in the UK, in a paper published this week in The Design Journal.

According to the group, the pandemic has highlighted serious flaws in a system that forces research groups around the world to start from scratch every time a tweak needs to be made to an existing instrument, simply because they can't get their hands on the original designs.

"The term 'open source' is being applied to the final design of an instrument - and I'm pleased to say there has been a willingness during the pandemic to share these final designs - but the design process itself also needs to be open, something it isn't now," explains physics researcher Dr Julian Stirling.

Dr Stirling uses a fictional scenario to describe the problem with the current model of open design: "Alice, a university researcher, gets public funding to create a new type of microscope, the NewScope. She spends two years developing this instrument and eventually gets it working.

A paper is published describing the principles behind her microscope, but the designs themselves are sold to a company. From these designs, the company produces the Fab NewScope. The instrument is popular with scientists and they are happy to buy it.

"Then Bob, another researcher, has an idea that will improve the Fab NewScope, and he gets public funding to make these improvements. But he doesn't have access to the designs for the NewScope, so he has to start from scratch. Bob spends two years creating his improved NewScope, 18 months of which are spent redesigning the original microscope. He makes most of the same mistakes as Alice and goes down many of the same dead ends.

"Eventually, the NewScope+ is complete and a paper describing the principles behind it is published, but the designs themselves are sold to a company. Some time later, Charlie has a great idea for improving NewScope+ and so the whole process of reinventing the NewScope starts again."

Dr Stirling believes complete openness is needed at every point in the design process, not least because hardware designs are generally generated by academics from public funds.

"If the public is funding a generation of knowledge, they should have access to it," he says. "For a company to collect the data that comes from this public-funded knowledge and then patent it seems a bit perverse to me."

During the pandemic, many large tech companies - including Amazon, Microsoft and IBM - have signed the Open COVID pledge in recognition of the need for them to apply every tool at their disposal to halt the pandemic and treat those affected. The pledge is to make intellectual property available free of charge where it can be put to use in the fight against Covid-19. Dr Stirling welcomes this gesture of goodwill but he points out that the pledge is time-limited.

"So when the next pandemic hits, we'll be back in the same situation."

This year has seen a surge in the development of ventilators to treat those most severely affected by the Covid virus, and participants of the open-source pledge have showed willing in sharing their ventilator designs. However, as Dr Stirling explains, for legitimate legal and liability reasons, many pledge signatories have adopted an open-when-finished model, meaning their final design plans are open for others to use but their engineering efforts happen behind closed doors, so remote teams aren't able to collaborate in real time.

"There has been a proliferation of projects with teams across the world independently designing over a hundred mutually incompatible ventilators," said Dr Stirling. "This a huge amount of duplicated effort."

Dr Stirling believes the way forward is for universities to give more support to staff who wish to engage in open design. He also calls on governments to clarify the liability of individual teams contributing to open design, so researchers are more willing to share their ideas throughout the design process without fearing they could face a lawsuit if a manufacturer produces a malfunctioning product from their prototype design. He also highlights that the regulatory process may be a barrier for open-source designs, as a manufacturer is required to understand and explain why a device has been designed the way it has.

"Ultimately, it is a device not a design that gets certified. It has to be this way as you don't want anyone manufacturing a ventilator - you want accredited trained professionals," said Dr Stirling. "If a manufacturer only sees your final design, how can they understand it enough to take legal responsibility? With an open design process, transferring this knowledge should be possible."

For the past five years the same research group has worked on the design for an open-source microscope that is now being adapted by individuals and organisations around the world. The 3D printed OpenFlexure Microscope is highly customisable, meaning it be can adapted for laboratory, school and home use. The project has evolved such that every step of the design process is openly available.

"The more we work in the open, the less time we waste re-explaining the same issues to collaborators. This body of knowledge about the design is so important for our Tanzanian collaborators as they work to develop the design into a certified medical diagnostic device."

Credit: 
University of Bath